Skip to main content
# Title Department Research Year
821 Enhanced dispersive solid phase extraction assisted
by cloud point strategy prior to fluorometric
determination of anti-hepatitis C drug velpatasvir in
pharmaceutical tablets and body fluids
Department of Pharmaceutical Analytical Chemistry 2018
822 Efficient HPTLC-dual wavelength spectrodensitometric method for simultaneous determination of sofosbuvir and daclatasvir: Biological and pharmaceutical analysis Department of Pharmaceutical Analytical Chemistry 2018
823 Novel Targeted Lipid Nanoparticles Loaded with Synergistic Chemotherapy- Gene therapy Combination for Effective Treatment of Hepatocellular Carcinoma Department of Industrial Pharmacy 2018
824 Novel N-Substituted 5-aminosalicylamides as Dual Inhibitors of Cyclooxygenase and 5-Lipoxygenase Enzymes: Synthesis, Biological Evaluation and Docking Study Department of Pharmaceutical Organic Chemistry 2018
825 Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer : Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model 2018
826 Enhancing Docetaxel Delivery to Multidrug-Resistant Cancer Cells with Albumin-Coated Nanocrystals Department of Pharmaceutics 2018
827 Simultaneous quantitation of direct acting hepatitis c antiviral binary mixture via efficient HPLC-dual wavelength detection method Department of Pharmaceutical Analytical Chemistry 2018
828 ROLE OF SELF-EMULSIFYING DRUG DELIVERY SYSTEMS IN ENHANCING THE ORAL BIOAVAILABILITY OF BCS CLASS II DRUGS Department of Pharmaceutics 2018
829 Fluorimetric determination of febuxostat in dosage forms and in real human plasma via Förster resonance energy transfer‏ Department of Pharmaceutical Analytical Chemistry 2018
830 Bis-(5-substituted-2-thiono-1,3,5-thiadiazinan-3-yl) Butane as a Scaffold of Anti-Proliferative Activity, Blended by a Multicomponent Process Department of Pharmaceutical Organic Chemistry 2018